• OPEN AN ACCOUNT
Indian Indices
Nifty
25,044.35 72.45
(0.29%)
Sensex
82,448.80 393.69
( 0.48%)
Bank Nifty
56,461.90 402.55
( 0.72%)
Nifty IT
38,417.95 3.85
( 0.01%)
Global Indices
Nasdaq
43,117.37 514.58
(1.21%)
Dow Jones
6,114.62 68.45
(1.13%)
Hang Seng
38,777.68 423.59
(1.10%)
Nikkei 225
8,758.99 0.95
(0.01%)
Forex
USD-INR
86.62 0.13
(0.15%)
EUR-INR
99.78 0.17
(0.17%)
GBP-INR
116.55 0.28
(0.24%)
JPY-INR
0.59 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Star Housing Finance Ltd
Industry :  Finance - Housing
BSE Code
ISIN Demat
Book Value()
539017
INE526R01028
18.1494438
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
26.38
293.67
EPS(TTM)
Face Value()
Div & Yield %
1.41
5
0.2
 

Aurobindo Pharma’s US arm incorporates Cresedemo Pharma
Jun 16,2025
The purpose of incorporating this new entity is to expand the company’s pharmaceutical products business in USA.

The company has subscribed to a share capital of $10,000 divided into 10,000 shares with a nominal value of $1 each.

Aurobindo Pharma is an integrated global pharmaceutical company headquartered in Hyderabad, India. The company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.

The company’s consolidated net profit fell 0.6% to Rs 903.47 crore despite a 11.9% jump in net sales to Rs 8,381.12 crore in Q4 FY25 over Q4 FY24.

The scrip declined 0.38% to end at Rs 1,150.65 on the BSE.